Drug Profile
Streptococcal B vaccine - Active Biotech
Latest Information Update: 06 Nov 2001
Price :
$50
*
At a glance
- Originator Active Biotech
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Streptococcal infections
Most Recent Events
- 06 Nov 2001 Discontinued-Preclinical for Streptococcal infections in United Kingdom (Unknown route)
- 14 Dec 2000 Actinova has been closed down
- 14 Dec 2000 Suspended-Preclinical for Streptococcal infections in United Kingdom (Unknown route)